ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 41 of 184 for:    "autosomal recessive cerebellar ataxia type 1" OR "Cerebellar Ataxia"

(+) Epicatechin to Treat Friedreich's Ataxia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02660112
Recruitment Status : Active, not recruiting
First Posted : January 21, 2016
Last Update Posted : November 1, 2017
Sponsor:
Collaborator:
Cardero Therapeutics, Inc.
Information provided by (Responsible Party):
Ralitza Gavrilova, Mayo Clinic

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : December 2018
  Estimated Study Completion Date : December 2018